GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HST Global Inc (OTCPK:HSTC) » Definitions » FCF Margin %

HST Global (HST Global) FCF Margin % : 0.00% (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is HST Global FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. HST Global's Free Cash Flow for the three months ended in Dec. 2023 was $-0.01 Mil. HST Global's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, HST Global's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, HST Global's current FCF Yield % is -0.35%.

The historical rank and industry rank for HST Global's FCF Margin % or its related term are showing as below:


HSTC's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -143.92
* Ranked among companies with meaningful FCF Margin % only.


HST Global FCF Margin % Historical Data

The historical data trend for HST Global's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HST Global FCF Margin % Chart

HST Global Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HST Global Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HST Global's FCF Margin %

For the Biotechnology subindustry, HST Global's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HST Global's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HST Global's FCF Margin % distribution charts can be found below:

* The bar in red indicates where HST Global's FCF Margin % falls into.



HST Global FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

HST Global's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.021/0
= %

HST Global's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.005/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HST Global FCF Margin % Related Terms

Thank you for viewing the detailed overview of HST Global's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


HST Global (HST Global) Business Description

Traded in Other Exchanges
N/A
Address
150 Research Drive, Hampton, VA, USA, 23666
HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.
Executives
Wesley D. Tate officer: CFO and Secretary C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Ronald R. Howell director, officer: CEO and Chairman C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Pnc Labs Inc 10 percent owner 429 W PLUMB LANE, RENO NV 89509
Chun Ka Tsun director, 10 percent owner, officer: CEO TG WANASPORTS MANAGEMENT HOLDINGS, 8/F NO 211 JOHNSTON ROAD, WAN CHAI K3 00000
Chen Tsz King 10 percent owner FUGU ENTERPRISE INC, UNIT A 8TH FLOOR NO 65 SING WOOD ROAD, HAPPY VALLEY K3 00000
Li Sze Tang 10 percent owner FLAT G, 8/FL TOWER THREE, THE WATERFRONT, 1 AUSTIN ROAD WEST, TST K3 00000
Andre E Todd director 746 HILLGIRT CIRCLE, OAKLAND CA 94610
Aaron Etra director 1350 AVE OF AMERICAS, 29TH FLOOR, NEW YORK NY 10019
Communications Holding Corp 10 percent owner
Alan Lew director, 10 percent owner, officer: President 2 DOGWOOD DR, SCARSDALE NY 10583

HST Global (HST Global) Headlines